Evidence map›Paper›PMID 36912903›Full record

ArticleApplied microbiology and biotechnology2023

Development of high-copy number plasmids in Pseudoalteromonas haloplanktis TAC125.

Marzia Calvanese, Cecilia Balestra, Andrea Colarusso, Concetta Lauro, Christopher Riccardi, Marco Fondi, Ermenegilda Parrilli, Maria Luisa Tutino

Open access · hybridFull text read
In one paragraph

Article in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Plasmid Curing ofBio-protocol · 2026
    Article
  2. Article
  3. Engineering the MarineMicroorganisms · 2025
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marzia CalvaneseDepartment of Chemical Sciences, Federico II University of Naples, Complesso Universitario Monte S.- Angelo, Via Cintia, 80126, Naples, Italy.
Cecilia BalestraIstituto Nazionale di Oceanografia e di Geofisica Sperimentale, Oceanography Division - OGS, Trieste, Italy.
Andrea ColarussoDepartment of Chemical Sciences, Federico II University of Naples, Complesso Universitario Monte S.- Angelo, Via Cintia, 80126, Naples, Italy.
Concetta LauroDepartment of Chemical Sciences, Federico II University of Naples, Complesso Universitario Monte S.- Angelo, Via Cintia, 80126, Naples, Italy.
Christopher RiccardiDepartment of Biology, Via Madonna del Piano 6, Sesto Fiorentino, 50018, Florence, Italy.
Marco FondiDepartment of Biology, Via Madonna del Piano 6, Sesto Fiorentino, 50018, Florence, Italy.
Ermenegilda ParrilliDepartment of Chemical Sciences, Federico II University of Naples, Complesso Universitario Monte S.- Angelo, Via Cintia, 80126, Naples, Italy.
Maria Luisa TutinoDepartment of Chemical Sciences, Federico II University of Naples, Complesso Universitario Monte S.- Angelo, Via Cintia, 80126, Naples, Italy. tutino@unina.it.ORCID http://orcid.org/0000-0002-4978-6839
University of Naples Federico II · ITIstituto Nazionale Biostrutture e Biosistemi · ITNational Institute of Oceanography and Applied Geophysics · IT

Funding

Italian National Antarctic Programme PNRA18_00335
6 · The paper itself

Abstract

The Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 (PhTAC125) is considered an interesting alternative host for the recombinant protein production, that can be explored when the conventional bacterial expression systems fail. Indeed, the manufacture of all the difficult-to-express proteins produced so far in this bacterial platform gave back soluble and active products. Despite these promising results, the low yield of recombinant protein production achieved is hampering the wider and industrial exploitation of this psychrophilic cell factory. All the expression plasmids developed so far in PhTAC125 are based on the origin of replication of the endogenous pMtBL plasmid and are maintained at a very low copy number. In this work, we set up an experimental strategy to select mutated OriR sequences endowed with the ability to establish recombinant plasmids at higher multiplicity per cell. The solution to this major production bottleneck was achieved by the construction of a library of psychrophilic vectors, each containing a randomly mutated version of pMtBL OriR, and its screening by fluorescence-activated cell sorting (FACS). The selected clones allowed the identification of mutated OriR sequences effective in enhancing the plasmid copy number of approximately two orders of magnitude, and the production of the recombinant green fluorescent protein was increased up to twenty times approximately. Moreover, the molecular characterization of the different mutant OriR sequences allowed us to suggest some preliminary clues on the pMtBL replication mechanism that deserve to be further investigated in the future. KEY POINTS: • Setup of an electroporation procedure for Pseudoalteromonas haloplanktis TAC125. • Two order of magnitude improvement of OriR-derived psychrophilic expression systems. • Almost twenty times enhancement in Green fluorescent protein production.

Indexed as

DNA Copy Number VariationsPseudoalteromonasGreen Fluorescent ProteinsPlasmidsRecombinant ProteinsGreen Fluorescent ProteinsRecombinant ProteinsCold-adapted bacteriaHigh-copy plasmidPseudoalteromonas haloplanktis TAC125Recombinant protein production

Identifiers

PMID36912903
PMCPMC10033558
OpenAlexW4324020921

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read90
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.